Annual report pursuant to Section 13 and 15(d)

Mergers and Acquisitions (Details)

v3.24.1.u1
Mergers and Acquisitions (Details)
Dec. 28, 2022
USD ($)
patent
$ / shares
shares
Dec. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Feb. 28, 2022
Business Acquisition [Line Items]        
Deferred tax liabilities   $ 639,000 $ 195,000  
Soin intangibles        
Business Acquisition [Line Items]        
Number of pending patents | patent 3      
Estimated useful life of intangible assets 10 years      
Dr. Soin | Related Party        
Business Acquisition [Line Items]        
Common stock, shares outstanding, percentage 4.99%      
Series S        
Business Acquisition [Line Items]        
Fair value of stock issued connection with merger $ 14,500,000      
Estimated useful life of intangible assets       10 years
Deferred tax liabilities 4,800,000      
Intangible assets $ 19,300,000 $ 17,800,000    
Series S | Stock Conversion 1 | Dr. Soin | Related Party        
Business Acquisition [Line Items]        
Conversion of stock, commencement period 1 year      
Series S | Stock Conversion 3 | Dr. Soin | Related Party        
Business Acquisition [Line Items]        
Conversion of stock, period after closing 10 years      
Soin Therapeutics LLC        
Business Acquisition [Line Items]        
Goodwill $ 0      
Soin Therapeutics LLC | Series S | Stock Conversion 1        
Business Acquisition [Line Items]        
Conversion of stock, amount converted 3,000,000      
Soin Therapeutics LLC | Series S | Stock Conversion 2        
Business Acquisition [Line Items]        
Conversion of stock, amount converted 10,000,000      
Soin Therapeutics LLC | Series S | Stock Conversion 3        
Business Acquisition [Line Items]        
Conversion of stock, amount converted $ 17,000,000      
Soin Therapeutics LLC | STI Merger Sub, Inc.        
Business Acquisition [Line Items]        
Common stock, shares outstanding, percentage 4.99%      
Soin Therapeutics LLC | STI Merger Sub, Inc. | Series S        
Business Acquisition [Line Items]        
Preferred stock, shares authorized (in shares) | shares 200,000      
Convertible preferred stock, par value (in usd per share) | $ / shares $ 300.00      
Stock issued during period, shares, acquisition (in shares) | shares 100,000      
Stock issued during period, value, acquisition $ 13,000,000      
Stock issued during period, additional value, acquisitions 17,000,000      
Business acquisition, shares issued, fair value $ 30,000,000